Patents by Inventor Marc D'Haulluin

Marc D'Haulluin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12370370
    Abstract: An apparatus for monitoring a patient post operation having electrically conducting leads which are adapted to extend from inside the patient. The leads having electrodes adapted to communicate with a heart of the patient and apply electrical signals to the heart. The electrodes providing cardiac signals to the computer in response to the electrical signals so the computer can determine in real time at least one of heart volume, end diastolic heart volume, end systolic heart volume, stroke volume, change in heart volume, change in stroke volume, contractility, respiration rate or tidal volume regarding the patient.
    Type: Grant
    Filed: October 7, 2022
    Date of Patent: July 29, 2025
    Assignee: Board of Regents, The University of Texas System
    Inventors: Jonathan W. Valvano, John A. Pearce, Marc D. Feldman, Kaarthik Rajendran, John Porterfield, Anil Kottam, Wes Johnson
  • Patent number: 12365039
    Abstract: An example shearing head includes a first member and a second member being rotatable about a pin. The first member has a shearing surface forming a substantially right angle with a first lateral surface of the first member. The second member has a shearing surface forming a substantially right angle with a second lateral surface of the second member. The second member includes a first distal surface and a second distal surface forming a substantially right angle. The first distal surface and the second distal surface are substantially perpendicular to the second lateral surface. The second member includes a third lateral surface opposing the second lateral surface and a retainer is attached to the second member. A first surface of the retainer contacts the first distal surface, a second surface of the retainer contacts the second distal surface, and the third lateral surface contacts a third surface of the retainer.
    Type: Grant
    Filed: August 31, 2021
    Date of Patent: July 22, 2025
    Assignee: Milwaukee Electric Tool Corporation
    Inventor: Marc D'Antuono
  • Publication number: 20250231109
    Abstract: Described are methods for detecting an analyte in a liquid sample using negligible depletion and a fluorophore adhered to a solid phase extraction membrane.
    Type: Application
    Filed: January 10, 2025
    Publication date: July 17, 2025
    Inventors: Ling Zang, Marc D. Porter, Rana Dalapati, Soumen Saha
  • Patent number: 12362838
    Abstract: Method, system and computer program product for providing real time detection of analyte sensor sensitivity decline is continuous glucose monitoring systems are provided.
    Type: Grant
    Filed: June 16, 2023
    Date of Patent: July 15, 2025
    Assignees: ABBOTT DIABETES CARE INC., UNIVERSITY OF VIRGINIA PATENT FOUNDATION
    Inventors: Marc D. Breton, Boris P. Kovatchev, Erwin S. Budiman, Kenneth J. Doniger
  • Publication number: 20250215006
    Abstract: Disclosed are compounds of Formula (I), methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing, or ameliorating diseases or disorders such as cancer or infections.
    Type: Application
    Filed: October 14, 2024
    Publication date: July 3, 2025
    Applicant: Incyte Corporation
    Inventors: Yanran Ai, Joe Barbosa, Ananda Ghosh, Marc D. Deller, Joe Glenn, JR., Leslie McQuirter, Yehao Qiu, Lixin Shao, Stacey Shepard, Cooper Taylor, Xiaozhao Wang, Eddy Yue, Guofeng Zhang
  • Patent number: 12336847
    Abstract: A system for generating a hypoglycemia risk signal associated with exercise-induced Hypoglycemia. The system can include a processor configured to obtain a blood glucose signal (BGstart), a ratio of absolute insulin on board over total daily insulin signal (IOBabs/TDI), and an initial glycemic slope signal (S0); generate a hypoglycemia risk signal based on a hypoglycemia prediction algorithm that determines the probability of a user being hypoglycemic during or after exercise based on the obtained BGstart, IOBabs/TDI and S0.
    Type: Grant
    Filed: March 6, 2024
    Date of Patent: June 24, 2025
    Assignee: UNIVERSITY OF VIRGINIA PATENT FOUNDATION
    Inventors: Marc D. Breton, Najib Ben-Brahim
  • Patent number: 12331643
    Abstract: An apparatus is for installing support for a surface of a mine passage, such as a mine roof, using an object, such as a roof bolt. The apparatus includes a driver adapted to advance toward the surface for driving the object into the surface. A gripper includes first and second arms for gripping the object in a deployed position, such as upper and lower arms. The arms are linked such that engagement by one of the arms with the driver during advance causes the arms to retract towards each other (downwardly, for example, in the case of the upper arm, and upwardly, for example, in the case of the lower arm). Related methods are also disclosed.
    Type: Grant
    Filed: June 25, 2021
    Date of Patent: June 17, 2025
    Assignee: J.H. FLETCHER & CO.
    Inventors: Nathan U. Payne, Marc D. Endicott, Gregory E. Hinshaw, Timothy D. Burgess
  • Patent number: 12332677
    Abstract: A building manager includes a communications interface configured to receive time-of-use information from a smart energy grid and a processing circuit configured to process the time-of-use information received from the smart energy grid to generate load shedding decisions for building subsystems or devices including determining when to utilize energy from energy storage equipment. The processing circuit is configured to determine an amount of greenhouse gas emissions corresponding to the load shedding decisions and convert the amount of greenhouse gas emissions into tradable carbon credits. The processing circuit is configured to generate a graphical user interface including modules indicating the amount of greenhouse gas emissions, the tradable carbon credits, or energy savings resulting from the load shedding decisions.
    Type: Grant
    Filed: March 11, 2024
    Date of Patent: June 17, 2025
    Assignee: Johnson Controls Technology Company
    Inventors: Clay G. Nesler, Kirk H. Drees, James P. Kummer, Derek Supple, Marc D. Andraca, John I. Ruiz, Paul Harrison Rode
  • Patent number: 12324682
    Abstract: A flexible system for utilizing data from different monitoring techniques and capable of providing assistance to patients with diabetes at several scalable levels, ranging from advice about long-term trends and prognosis to real-time automated closed-loop control (artificial pancreas). These scalable monitoring and treatment strategies are delivered by a unified system called the Diabetes Assistant (DiAs) platform. The system provides a foundation for implementation of various monitoring, advisory, and automated diabetes treatment algorithms or methods. The DiAs recommendations are tailored to the specifics of an individual patient, and to the patient risk assessment at any given moment.
    Type: Grant
    Filed: February 13, 2020
    Date of Patent: June 10, 2025
    Assignee: UNIVERISTY OF VIRGINIA PATENT FOUNDATION
    Inventors: Boris P. Kovatchev, Patrick T. Keith-Hynes, Marc D. Breton, Stephen D. Patek
  • Publication number: 20250182874
    Abstract: An insulin delivery supervisor (IDS) with a safety analysis and supervision function that can reside between the insulin request and the insulin delivery and can intercept any excessive insulin requests before the insulin was delivered. The IDS can be implemented in any system based on insulin pump or pen and will work with either SMBG or CGM modes of blood glucose monitoring.
    Type: Application
    Filed: February 4, 2025
    Publication date: June 5, 2025
    Applicant: UNIVERSITY OF VIRGINIA PATENT FOUNDATION
    Inventors: Marc D. BRETON, Stephen D. PATEK, Boris P. KOVATCHEV, Colleen H. KARVETSKI
  • Patent number: 12311513
    Abstract: Embodiments of the invention provide a ram guide for a crimping tool. The crimping tool includes a crimping head and a ram head. The ram guide includes a track and slot. The ram guide is configured to guide the ram head within a crimp portion of the crimping head to axially align the ram head with the crimping head.
    Type: Grant
    Filed: April 29, 2022
    Date of Patent: May 27, 2025
    Assignee: Milwaukee Electric Tool Corporation
    Inventors: Johnathan Ashley, Marc D'Antuono
  • Patent number: 12311025
    Abstract: Formulations, are used for eye treatments, e.g., cross-linking treatments. For example, a therapeutic formulation includes a photosensitizer and delivery agent(s), wherein the delivery agent(s) include at least one of: anesthetic agent(s), analgesic agent(s), tonicity agent(s), or shear-thinning, or viscosity-increasing agent(s). In another example, a method includes applying preparatory formulation(s) to increase a permeability of a corneal epithelium, and applying therapeutic formulation(s) to the epithelium, where the preparatory formulation(s) include zinc metalloproteinase, copper metalloproteinase, papain, bromelain, actinidin, ficain, N-acetylcysteine, ambroxol, carbocisteine, and/or erdosteine.
    Type: Grant
    Filed: July 20, 2020
    Date of Patent: May 27, 2025
    Assignee: Avedro, Inc.
    Inventors: Marc D. Friedman, Pavel Kamaev, Martin Joseph Coffey, Rajesh K. Rajpal, Alexandra Nicklin
  • Publication number: 20250160694
    Abstract: An aspect of an embodiment or partial embodiment of the present invention (or combinations of various embodiments in whole or in part of the present invention) comprises, but not limited thereto, a method and system (and related computer program product) for continually assessing the risk of hypoglycemia for a patient and then determining what action to take based on that risk assessment. A further embodiment results in two outputs: (1) an attenuation factor to be applied to the insulin rate command sent to the pump (either via conventional therapy or via open or closed loop control) and/or (2) a red/yellow/green light hypoglycemia alarm providing to the patient an indication of the risk of hypoglycemia. The two outputs of the CPHS can be used in combination or individually.
    Type: Application
    Filed: January 17, 2025
    Publication date: May 22, 2025
    Applicant: UNIVERSITY OF VIRGINIA PATENT FOUNDATION
    Inventors: Boris P. KOVATCHEV, Marc D. BRETON, Stephen D. PATEK
  • Publication number: 20250160695
    Abstract: An aspect of an embodiment or partial embodiment of the present invention (or combinations of various embodiments in whole or in part of the present invention) comprises, but not limited thereto, a method and system (and related computer program product) for continually assessing the risk of hypoglycemia for a patient and then determining what action to take based on that risk assessment. A further embodiment results in two outputs: (1) an attenuation factor to be applied to the insulin rate command sent to the pump (either via conventional therapy or via open or closed loop control) and/or (2) a red/yellow/green light hypoglycemia alarm providing to the patient an indication of the risk of hypoglycemia. The two outputs of the CPHS can be used in combination or individually.
    Type: Application
    Filed: January 17, 2025
    Publication date: May 22, 2025
    Applicant: UNIVERSITY OF VIRGINIA PATENT FOUNDATION
    Inventors: Boris P. KOVATCHEV, Marc D. BRETON, Stephen D. PATEK
  • Publication number: 20250161452
    Abstract: A formulation for an eye treatment includes a photosensitizer and a permeability enhancing composition. The permeability enhancing composition includes one or more permeability enhancers. The permeability enhancing composition has a hydrophilic and lipophilic balance increases a permeability of an area of the eye for the photosensitizer. The hydrophilic and lipophilic balance can be characterized by a Hydrophile-Lipophile Balance (HLB) number. For example, the area of the eye may include a corneal epithelium, the photosensitizer may include riboflavin, and the permeability enhancing composition may have a corresponding HLB number between approximately 12.6 and approximately 14.6.
    Type: Application
    Filed: January 17, 2025
    Publication date: May 22, 2025
    Inventors: Pavel Kamaev, Marc D. Friedman
  • Publication number: 20250160696
    Abstract: An aspect of an embodiment or partial embodiment of the present invention (or combinations of various embodiments in whole or in part of the present invention) comprises, but not limited thereto, a method and system (and related computer program product) for continually assessing the risk of hypoglycemia for a patient and then determining what action to take based on that risk assessment. A further embodiment results in two outputs: (1) an attenuation factor to be applied to the insulin rate command sent to the pump (either via conventional therapy or via open or closed loop control) and/or (2) a red/yellow/green light hypoglycemia alarm providing to the patient an indication of the risk of hypoglycemia. The two outputs of the CPHS can be used in combination or individually.
    Type: Application
    Filed: January 17, 2025
    Publication date: May 22, 2025
    Applicant: UNIVERSITY OF VIRGINIA PATENT FOUNDATION
    Inventors: Boris P. KOVATCHEV, Marc D. BRETON, Stephen D. PATEK
  • Patent number: 12295732
    Abstract: Featured are urodynamic catheters, intravaginal devices, and intrarectal devices, systems and kits thereof, and methods of using the devices, systems, and kits to observe pelvic floor movements in order to monitor bladder function in order to diagnose, treat, or prevent urinary incontinence disorders, such as urge incontinence and stress incontinence.
    Type: Grant
    Filed: October 29, 2019
    Date of Patent: May 13, 2025
    Assignee: Axena Health, Inc.
    Inventors: Marc D. Beer, Samantha J. Pulliam, Jessica L. McKinney
  • Patent number: 12285589
    Abstract: An insulin monitoring system includes one or more processors, one or more computer-readable storage devices, and program instructions stored on at least one of the one or more storage devices for execution by at least one of the one or more processors. The program instructions include: first program instructions to track, in real time, the amount of insulin active in a patient; second program instructions to calculate the amount of insulin need of the patient by tracking the patient's metabolic states; third program instructions to compare the insulin active in the patient with the insulin need of the patient; and fourth program instructions to determine an insulin fault level based on the comparison.
    Type: Grant
    Filed: March 8, 2024
    Date of Patent: April 29, 2025
    Assignee: UNIVERSITY OF VIRGINIA PATENT FOUNDATION
    Inventors: Marc D. Breton, Stephen D. Patek, Boris P. Kovatchev
  • Publication number: 20250107703
    Abstract: Exemplary embodiments of the present disclosure include systems and methods for treatment of occlusions, including coronary artery chronic total occlusions.
    Type: Application
    Filed: December 13, 2024
    Publication date: April 3, 2025
    Applicant: RESEARCH DEVELOPMENT FOUNDATION
    Inventors: Marc D. FELDMAN, Thomas E. MILNER, Nitesh KATTA, Arnold ESTRADA, Meagan OGLESBY, Andrew Giles CABE, Mehmet CILINGIROGLU
  • Patent number: 12266436
    Abstract: An insulin delivery supervisor (IDS) with a safety analysis and supervision function that can reside between the insulin request and the insulin delivery and can intercept any excessive insulin requests before the insulin was delivered. The IDS can be implemented in any system based on insulin pump or pen and will work with either SMBG or CGM modes of blood glucose monitoring.
    Type: Grant
    Filed: June 4, 2021
    Date of Patent: April 1, 2025
    Assignee: UNIVERSITY OF VIRGINIA PATENT FOUNDATION
    Inventors: Marc D. Breton, Stephen D. Patek, Boris P. Kovatchev, Colleen H. Karvetski